Zolmitriptan Tablet, Film Coated
Product Images NDC 68001-249

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 68001-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zolmitriptan Tablets, 2.5 mg 6 Unit Dose Ndc 68001-249-01 (Carton Zolmitriptan Tablets 2 5 mg Rev 0714)

Zolmitriptan Tablets, 2.5 mg 6 Unit Dose Ndc 68001-249-01 (Carton Zolmitriptan Tablets 2 5 mg Rev 0714)
FDA Label Image

Zolmitriptan Tablets 5mg Ndc 68001-250-01, 3 Unit Dose Tablets (Carton Zolmitriptan Tablets 5 mg Rev 0714)

Zolmitriptan Tablets 5mg Ndc 68001-250-01, 3 Unit Dose Tablets (Carton Zolmitriptan Tablets 5 mg Rev 0714)
FDA Label Image

Zolmitriptan Structual Formula (E6628b7a 0b63 4e6f A5e7 2fa195265235 01)

Zolmitriptan Structual Formula (E6628b7a 0b63 4e6f A5e7 2fa195265235 01)
FDA Label Image

Figure 1 (E6628b7a 0b63 4e6f A5e7 2fa195265235 02)

Figure 1 (E6628b7a 0b63 4e6f A5e7 2fa195265235 02)
FDA Label Image

Figure 2 The Estimated Probability Of Patients Taking A Second Dose Or Other Medication For Migraines Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Studies 2, 3, And 5 (E6628b7a 0b63 4e6f A5e7 2fa195265235 03)

Figure 2 The Estimated Probability Of Patients Taking A Second Dose Or Other Medication For Migraines Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Studies 2, 3, And 5 (E6628b7a 0b63 4e6f A5e7 2fa195265235 03)